Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.59 | 2.47 |
| PEG Ratio (TTM) | 0.81 | -2.16 |
| P/S Ratio (TTM) | 0.20 | 1.15 |
| P/B Ratio (TTM) | 2.88 | 1.61 |
| P/FCF Ratio (TTM) | 4.74 | 3.23 |
| Price to 5YR AVG Earnings Ratio | -0.95 | -9.93 |
| Price to 5YR AVG FCF Ratio | 3.45 | 7.49 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.38% | -3.81% |
| ROE (TTM) | -58.29% | -42.13% |
| Net Profit Margin (TTM) | -5.25% | 3.36% |
| ROIC 5YR AVG | -21.99% | -1.62% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -29.51% | 7.07% | 31.40% |
| Revenue | -0.07% | -11.94% | 1.80% |
| Net Income | -29.88% | 3.49% | 27.52% |
| Cash Flow | 10.94% | 27.94% | 25.60% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.88 | 2.02 |
| Quick Ratio (TTM) | 1.63 | 1.88 |
| D/E Ratio (TTM) | 13.11 | 1.24 |
| Interest Coverage (TTM) | 1.22 | 2.75 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 0.34 | 1.38 |
| LTL to 5YR AVG FCF | 15.19 | -66.65 |
| Shares Outstanding Growth 5YR AVG | 6.64% | 3.35% |